Onderneming Tetra Bio Pharma Inc Canadian Securities Exchange
Aandelen
TBP
CA88166Y1007
Farmaceutische producten
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Guy Chamberland
CEO | Chief Executive Officer | - | 01-06-16 |
Natalie Leroux
IRC | Investor Relations Contact | - | - |
Michael Olders
PRN | Corporate Officer/Principal | - | - |
Derek Theriault
PRN | Corporate Officer/Principal | - | - |
Dania Scott
PRN | Corporate Officer/Principal | - | 04-09-20 |
Aurelia de Pauw
PRN | Corporate Officer/Principal | - | 01-10-18 |
Steeve Néron
PRN | Corporate Officer/Principal | - | 13-11-18 |
Corporate Officer/Principal | - | 05-06-18 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Guy Chamberland
CEO | Chief Executive Officer | - | 01-06-16 |
Catherine Auld
BRD | Director/Board Member | - | 28-05-21 |
H. Norton
CHM | Chairman | 63 | 17-09-20 |
Director/Board Member | 68 | 17-09-20 | |
John Kim
BRD | Director/Board Member | - | 28-05-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 515 634 205 | 510 507 769 ( 99,01 %) | 0 | 99,01 % |
Bedrijfsgegevens
![Adres Tetra Bio Pharma Inc(TBP)](https://cdn.zonebourse.com/static/address/33624451.png)
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+29,99% | 5,69 mld. | |
-31,99% | 3,53 mld. | |
-0,59% | 3,06 mld. | |
-24,15% | 2,62 mld. | |
-9,23% | 2,29 mld. | |
+42,55% | 1,86 mld. | |
+44,37% | 1,43 mld. | |
-11,29% | 1,41 mld. | |
+42,86% | 1,4 mld. |